Back
Warrior Met Coal Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
42
HCC
Warrior Met Coal
Last Price:
$56.91
Seasonality Move:
-1.26%
Buy
52
BMRN
Biomarin Pharmaceutical
Last Price:
$62.13
Seasonality Move:
-2.99%
Sell
42
Warrior Met Coal (HCC)
is a Sell
Is Warrior Met Coal a Buy, Sell or Hold?
-
The current Warrior Met Coal [HCC] share price is $56.06. The Score for HCC is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
HCC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $61.53. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HCC Stock Price Chart
What is Warrior Met Coal's stock price today?
-
The Warrior Met Coal share price today is $56.06The current trend is relatively stagnant and HCC is experiencing buying pressure, which is a positive indicator for future bullish movement.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $61.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
HCC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.08 | Sell |
Relative Strength Index (14 RSI): | 48.24 | Sell |
Chaikin Money Flow: | 790522 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.3 - 58.96) | Buy |
Bollinger Bands (100): | (54.82 - 67.06) | Sell |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 32.71 | Sell |
Chaikin Money Flow: | -1783794 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.88 - 67.6) | Sell |
Bollinger Bands (100): | (62.43 - 78.09) | Sell |
HCC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.34 | Buy |
20-day SMA: | 54.17 | Buy |
50-day SMA: | 62.25 | Sell |
200-day SMA: | 63.07 | Sell |
8-day EMA: | 54.15 | Buy |
20-day EMA: | 55.42 | Buy |
50-day EMA: | 58.97 | Sell |
200-day EMA: | 60.65 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.85 | Sell |
20-day SMA: | 65.63 | Sell |
50-day SMA: | 65.49 | Sell |
200-day SMA: | 77.22 | Sell |
8-day EMA: | 63.78 | Sell |
20-day EMA: | 65.11 | Sell |
50-day EMA: | 66.54 | Sell |
200-day EMA: | 75.24 | Sell |
Warrior Met Coal Earnings Growth & HCC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.82 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
Warrior Met Coal Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |